Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 2,772 results for "Product Liability Law & Strategy"...

IN THE MARKETPLACE
September 11, 2003
Highlights of the latest equipment leasing news from around the country.
CASES IN COURT
September 11, 2003
A New Jersey medical magazine publisher recently agreed to pay $3.7 million to settle allegations it defrauded the postal service. On July 2, 2003, the U.S. Attorney's Office for the District of New Jersey issued a press release announcing that Medical World Communications, a Jamesburg, NJ, publisher, agreed to settle civil False Claims Act allegations that it defrauded the government over a 6-year period (1994 to 2000) through a scheme by which it inflated the number of subscribers to obtain a lower rate, thereby failing to pay adequate postage for mailing its periodicals.
Why We Need a No-Fault Compensation System for Drug Injuries
September 11, 2003
Part One of a Two-Part Article. The FDA's approval of a prescription drug or biologic is the product of an often-delicate risk-benefit analysis of public benefit as opposed to individual safety. The therapeutic balance of these products must always be weighed against the risks inherent in their use. And there are always inherent risks associated with their use. Accordingly, while millions of Americans reap the benefits of prescription drugs every day, these same drugs may pose an unavoidable health hazard to a narrow, and often unidentifiable, subset of potential users. The American legal system currently regulates these risks by two means ' through the federal regulatory system as administered by the FDA, and through the common-law tort liability regime.
Avoiding the Pitfalls of Stipulated Settlements
September 07, 2003
An officer of a corporation is named as a defendant in a shareholder derivative suit. After reading the complaint, which includes allegations that the officer committed a breach of certain fiduciary duties owed to the corporation, the officer promptly notifies his directors and officers' liability insurer of the lawsuit. Because the applicable policy contains exclusions that may potentially exclude some, if not all, of the claims, the insurer agrees to defend the officer subject to a full and complete reservation of rights.
Cybersticks and Cyberstones: Cybergriping after Bear Sterns and Taubman Company
September 07, 2003
Cybergriping occurs when one party (a 'cybergriper') i) establishes a Web site (the 'complaint site' or 'attack site') dedicated to the publication of complaints, claims, criticism, or parody of or against another party (the 'target company'), and ii) registers the Web site under a domain name comprised of the target's trademark and a pejorative suffix, such as 'sucks.com,' 'crooks.com' or 'ripoff.com.' Not surprisingly, target companies have attempted to combat this relatively new form of asymmetrical cyberwarfare by bringing suit against cybergripers under various legal theories, including trademark infringement, trademark dilution and cybersquatting.
IP NEWS
September 05, 2003
Highlights of the latest intellectual property cases from around the country.
Package Patent Licensing After <i>Microsoft</i>
September 05, 2003
The law governing package licensing of patents is currently undergoing a significant change. Historically, package licenses were subject to a 'per se' liability under the controlling legal doctrines. Using this per se test, a package license could be rendered unenforceable absent any inquiry into the actual market effects of the license. The recent case of <i>United States v. Microsoft,</i> 253 F.3d 34 (D.C. Cir. 2001), marks, however, the emergence of an antitrust doctrine called the 'rule of reason' that is likely to become the dominant legal doctrine for testing package licensing of patents. This is a significant change because the rule of reason is a market-based approach that balances the anticompetitive and pro-competitive benefits of the licensing practice. Thus, a package license may be held to be enforceable even if it would have failed the traditional per se test of the patent misuse doctrine or antitrust laws.
Origin of Goods Under the Lanham Act: An Analysis of the Supreme Court's Decision in Dastar Corp. v. Twentieth Century Fox Film Corp.
September 05, 2003
The Copyright Act and Patent Act were designed to protect originality and creativity. Courts, however, have generally been cautious about misusing or overextending the Lanham Act to areas traditionally occupied by patent or copyright law. <i>See TrafFix Devices, Inc. v. Marketing Displays, Inc.</i>, 532 U.S. 23, 29 (2001).
Direct Evidence Not Required in Mixed Motive Case
September 02, 2003
Last month, the Supreme Court was asked to decide whether a plaintiff must present direct evidence of discrimination in order to obtain a mixed-motive instruction under Title VII, as amended by the Civil Rights Act of 1991. <i>Desert Palace, Inc. v. Costa</i>, 2003 WL 21310219 (U.S. June 9, 2003) The Court unanimously held that direct evidence is not required.
CASE NOTES
September 02, 2003
Highlights of the latest product liability cases from around the country.

MOST POPULAR STORIES